[Experimental Pilot Study on Surface Activation of Implants with Liposomal Vectors]

Overview

Journal Mund Kiefer Gesichtschir

Specialties Dentistry
General Surgery

Date 2004 Aug 5

PMID 15293121

Citations 2

Authors

M Thorwarth

K A Schlegel

J Wiltfang

S Rupprecht

J H Park

Affiliations

Soon will be listed here.

Abstract

Background: Surface coating with mitogenic or morphogenic proteins can improve the healing of bone adjacent to implants and increase the bone-implant interface. Clinical surveys have shown liposome-mediated gene transfer to be a promising and safe new therapeutic method. The aim of our study was to evaluate an experimental model of new approaches for topical treatment of the implant surface and of periimplant defects by using DNA liposomes encoding for BMP-2 (bone morphogenetic protein).

Material And Methods: A total of 27 implants (3.5 x 14 mm) were placed in critically sized defects of the frontal skull bone of adult pigs (n=3). The bottom of the implant was placed in the base of the defect which guaranteed primary stability, whereas the superior part of the implant (10 mm) represented an implant in a defect area. Liposomes containing DNA encoding for BMP-2 and GFP (green fluorescence protein) were used. In a first trial GFP-DNA liposomes on a collagen matrix were directly applied to the periimplant defect. In a second stage, the surface of the implants was encoded with BMP-2 DNA liposomes. Subsequently, these implants were inserted in the manner described. The resulting bone samples were prepared for immunohistochemical staining. Staining for GFP was performed in the area of the defect and for BMP-2 on the bone-implant interface.

Results: Immunohistochemical staining on day 3 postoperatively revealed an increased GFP expression in the periimplant defect. Therefore, the effectiveness of the liposomal vector was verified for the chosen animal model. On the surface of the implants encoded with BMP-2 DNA liposomes an increased BMP-2 expression was found. Thus, the liposomal vector system was validated also for BMP-2 DNA transfer in the chosen animal model. Further, the established system allows a sustainable and delayed release of BMP-2 in the area of the bone-implant interface.

Conclusions: As a result of the study we were able to collect data concerning the influence of implant surface conditioning on the bone-implant interface and on therapeutically relevant options for the treatment of periimplant defects. These approaches are currently being evaluated in a long-term study.

Citing Articles

Implants in bone: part I. A current overview about tissue response, surface modifications and future perspectives.

von Wilmowsky C, Moest T, Nkenke E, Stelzle F, Schlegel K Oral Maxillofac Surg. 2013; 18(3):243-57.

PMID: 23435578 DOI: 10.1007/s10006-013-0398-1.

[Regeneration instead of reparation: a critical review of the autogenous bone transplant as "golden standard" of reconstructive oral surgery].

Horch H, Pautke C Mund Kiefer Gesichtschir. 2006; 10(4):213-20.

PMID: 16802135 DOI: 10.1007/s10006-006-0004-x.

References

Abrahamsson I, Zitzmann N, Berglundh T, Wennerberg A, Lindhe J . Bone and soft tissue integration to titanium implants with different surface topography: an experimental study in the dog. Int J Oral Maxillofac Implants. 2001; 16(3):323-32. View

Cochran D, Schenk R, Buser D, Wozney J, Jones A . Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. J Periodontol. 1999; 70(2):139-50. DOI: 10.1902/jop.1999.70.2.139. View

Nkenke E, Kloss F, Wiltfang J, Schultze-Mosgau S, Radespiel-Troger M, Loos K . Histomorphometric and fluorescence microscopic analysis of bone remodelling after installation of implants using an osteotome technique. Clin Oral Implants Res. 2003; 13(6):595-602. DOI: 10.1034/j.1600-0501.2002.130604.x. View

Zabner J, Fasbender A, Moninger T, Poellinger K, Welsh M . Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem. 1995; 270(32):18997-9007. DOI: 10.1074/jbc.270.32.18997. View

Loser P, Huser A, Hillgenberg M, Kumin D, Both G, Hofmann C . Advances in the development of non-human viral DNA-vectors for gene delivery. Curr Gene Ther. 2002; 2(2):161-71. DOI: 10.2174/1566523024605555. View

Schierano G, Bellone G, CASSARINO E, Pagano M, Preti G, Emanuelli G . Transforming growth factor-beta and interleukin 10 in oral implant sites in humans. J Dent Res. 2003; 82(6):428-32. DOI: 10.1177/154405910308200605. View

Roemer K, Friedmann T . Concepts and strategies for human gene therapy. Eur J Biochem. 1992; 208(2):211-25. DOI: 10.1111/j.1432-1033.1992.tb17176.x. View

Salata L, Franke-Stenport V, Rasmusson L . Recent outcomes and perspectives of the application of bone morphogenetic proteins in implant dentistry. Clin Implant Dent Relat Res. 2002; 4(1):27-32. DOI: 10.1111/j.1708-8208.2002.tb00148.x. View

Groeneveld E, Burger E . Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol. 2000; 142(1):9-21. DOI: 10.1530/eje.0.1420009. View

10.

Li S, Huang L . Nonviral gene therapy: promises and challenges. Gene Ther. 2000; 7(1):31-4. DOI: 10.1038/sj.gt.3301110. View

11.

Schilephake H . Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg. 2002; 31(5):469-84. DOI: 10.1054/ijom.2002.0244. View

12.

Reddi A . Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg Am. 2001; 83-A Suppl 1(Pt 1):S1-6. DOI: 10.2106/00004623-200100001-00001. View

13.

Marx R, Carlson E, Eichstaedt R, Schimmele S, Strauss J, Georgeff K . Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 85(6):638-46. DOI: 10.1016/s1079-2104(98)90029-4. View

14.

Lazzara R, Porter S, Testori T, Galante J, Zetterqvist L . A prospective multicenter study evaluating loading of osseotite implants two months after placement: one-year results. J Esthet Dent. 1999; 10(6):280-9. DOI: 10.1111/j.1708-8240.1998.tb00505.x. View

15.

Mitani K, Kubo S . Adenovirus as an integrating vector. Curr Gene Ther. 2002; 2(2):135-44. DOI: 10.2174/1566523024605591. View

16.

Cornelini R, Artese L, Rubini C, Fioroni M, Ferrero G, Santinelli A . Vascular endothelial growth factor and microvessel density around healthy and failing dental implants. Int J Oral Maxillofac Implants. 2001; 16(3):389-93. View

17.

Donath K, Breuner G . A method for the study of undecalcified bones and teeth with attached soft tissues. The Säge-Schliff (sawing and grinding) technique. J Oral Pathol. 1982; 11(4):318-26. DOI: 10.1111/j.1600-0714.1982.tb00172.x. View

18.

Miller A . The problem with cationic liposome/micelle-based non-viral vector systems for gene therapy. Curr Med Chem. 2003; 10(14):1195-211. DOI: 10.2174/0929867033457485. View

19.

Sigurdsson T, Fu E, Tatakis D, Rohrer M, Wikesjo U . Bone morphogenetic protein-2 for peri-implant bone regeneration and osseointegration. Clin Oral Implants Res. 1998; 8(5):367-74. DOI: 10.1034/j.1600-0501.1997.080503.x. View

20.

Sykaras N, Triplett R, Nunn M, Iacopino A, Opperman L . Effect of recombinant human bone morphogenetic protein-2 on bone regeneration and osseointegration of dental implants. Clin Oral Implants Res. 2001; 12(4):339-49. DOI: 10.1034/j.1600-0501.2001.012004339.x. View